A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2011
09/29/2011	US20110238016 Drug delivery to a joint
09/29/2011	US20110238000 Polymer-conjugated albumin hydrogels for controlled release of therapeutic agents
09/29/2011	US20110237785 Spatially-defined macrocyclic compounds useful for drug discovery
09/29/2011	US20110237655 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
09/29/2011	US20110237574 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
09/29/2011	US20110237525 Method of ameliorating oxidative stress and supplementing the diet
09/29/2011	US20110237524 Polymer conjugates of aod-like peptides
09/29/2011	US20110237523 CONTRACEPTIVE PEPTIDES DERIVED FROM THE VENOM OF THE SPIDER Latrodectus mirabilis, NUCLEOTIDE SEQUENCES TO TRANSFORM A MICROORGANISM TO PRODUCE SAID PEPTIDES; METHODS TO OBTAIN THE PEPTIDES; PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND USE THEREOF
09/29/2011	US20110237522 Neutral nanotransporters
09/29/2011	US20110237521 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
09/29/2011	US20110237520 Anticancer Compounds
09/29/2011	US20110237519 Hematopoietic Growth Factor Inducible Neurokinin-1 Gene and Uses Thereof
09/29/2011	US20110237518 Method for treating or preventing bladder cancer using the depdc1 polypeptide
09/29/2011	US20110237517 Iap inhibitors
09/29/2011	US20110237516 Plant-derived elastin binding protein ligands and methods of using the same
09/29/2011	US20110237515 Peptide derived from neurotesin receptor 3 and use thereof in the treatment of psychiatric diseases
09/29/2011	US20110237514 PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN
09/29/2011	US20110237513 Ltbp2 as a biomarker for renal dysfunction
09/29/2011	US20110237512 Methods for Treating Bleeding Disorders Using Sulfated Polysaccharides
09/29/2011	US20110237511 EP4 Receptor Agonist, Compositions and Methods Thereof
09/29/2011	US20110237510 Stabilized glucagon solutions
09/29/2011	US20110237509 hGH AND METHODS FOR PREPARING hGH
09/29/2011	US20110237508 Peptide Formulations and Uses Thereof
09/29/2011	US20110237507 Methods of protecting against apoptosis using lipopeptides
09/29/2011	US20110237506 Protein stabilization formulations
09/29/2011	US20110237505 Compositions and Methods for Treating Obesity and Diabetes
09/29/2011	US20110237504 Delivery agents for enhancing mucosal absorption of therapeutic agents
09/29/2011	US20110237503 Novel peptides and methods for their preparation and use
09/29/2011	US20110237501 Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1
09/29/2011	US20110237500 Cecropin-magainin hybrid peptides
09/29/2011	US20110237499 Hybrid tripyrrole-octaarginine compounds and their use as medicament in the treatment of cancer and microbial illnesses
09/29/2011	US20110237498 Soluble polypeptides for use in treating autoimmune and inflammatory disorders
09/29/2011	US20110237497 Compositions of a v-atpase inhibitor in combination with a glucocorticoid receptor ligand and methods of use
09/29/2011	US20110237496 Antinecrotic activity of alpha 1-antitrypsin
09/29/2011	US20110237495 Functional metabolomics coupled microfluidic chemotaxis device and identification of novel cell mediators
09/29/2011	US20110237494 Use of peptidic vasopression receptor agonists
09/29/2011	US20110237493 Dipeptide linked medicinal agents
09/29/2011	US20110237492 Treatment of diseases and conditions mediated by increased phosphorylation
09/29/2011	US20110236975 Growth factor which acts through erb b-4 rtk
09/29/2011	US20110236973 Centrosome proteins and uses thereof
09/29/2011	US20110236685 Therapeutic calcium phosphate particles and methods of manufacture and use
09/29/2011	US20110236508 L-arginine-based formulation for oral absorption
09/29/2011	US20110236502 Vitamin Strip (V1)
09/29/2011	US20110236501 Injectable dual delivery allograph bone/polymer composite for treatment of open fractures
09/29/2011	US20110236491 Topical anti-inflammatory composition
09/29/2011	US20110236485 Shell and core dosage form approaching zero-order drug release
09/29/2011	US20110236471 Platinum complexes and methods for inhibiting tumor cell proliferation
09/29/2011	US20110236469 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
09/29/2011	US20110236467 Method for erectile function potentiation by pharmaceutical compositions comprising toxin tx2-6 of the spider phoneutria nigriventer
09/29/2011	US20110236461 Methods for stimulating chondrogenesis utilizing a potassium channel inhibitor
09/29/2011	US20110236459 Therapeutic Implant
09/29/2011	US20110236456 Implantable device for the delivery of histrelin and methods of use thereof
09/29/2011	US20110236455 Novel Regulators of the Innate Immune System
09/29/2011	US20110236454 Injectable drug delivery formulation
09/29/2011	US20110236432 Coated Medical Device and Method of Coating a Medical Device to Reduce Fibrosis and Capsule Formation
09/29/2011	US20110236429 Small Cationic Antimicrobial Peptides
09/29/2011	US20110236428 Combination therapy with peptide epoxyketones
09/29/2011	US20110236418 Materials and Methods for Improved Vaccination
09/29/2011	US20110236412 Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine
09/29/2011	US20110236405 Coagulation factor modulation for controlling transplant organ size
09/29/2011	US20110236397 Limited proteolysis of cd2ap and progression of renal disease
09/29/2011	US20110236396 Methods and compositions for diagnosing and treating a colorectal adenocarcinoma
09/29/2011	US20110236394 Methods for the regulation of the prostaglandin f synthase (pgfs) activity of akr1b1 and uses thereof
09/29/2011	US20110236392 Composition and method for treatment of preterm labor
09/29/2011	US20110236389 Human Angiostatin Interacting and Tumor Metastasis Involving Protein Variants and Uses Thereof
09/29/2011	US20110236384 Direct drug delivery system based on thermally responsive biopolymers
09/29/2011	US20110236383 Protein Formulation
09/29/2011	US20110236382 Immunosuppressive combination and its use in the treatment or prophylaxis of insulin-producing cell graft rejection
09/29/2011	US20110236381 Inhibition of inter-alpha trypsin inhibitor for the treatment of airway disease
09/29/2011	US20110236371 Compositions And Methods For The Treatment Of Neurologic And Psychiatric Conditions
09/29/2011	US20110236370 Genetic Alterations on Chromosomes 21q, 6q and 15q and Methods of Use Thereof for the Diagnosis and Treatment of Type I Diabetes
09/29/2011	US20110236369 Dosage Forms That Facilitate Rapid Activation of Zymogen
09/29/2011	US20110236368 Oral medication for the treatment of hemorrhoids and method of use
09/29/2011	US20110236367 Rat cathespin dipeptidyl peptidase i (dppi): crystal structure and its uses
09/29/2011	US20110236366 Production and uses of type i ribosome inactivating proteins
09/29/2011	US20110236365 Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage
09/29/2011	US20110236364 Compositions containing non-polar compounds
09/29/2011	US20110236359 Antimicrobial Activity of Bacteriocin-Producing Lactic Acid Bacteria
09/29/2011	US20110236353 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
09/29/2011	US20110236352 PEGylation by the Dock and Lock (DNL) Technique
09/29/2011	US20110236351 Therapeutic Regimen Comprising PEG-Interferon, Ribavirin and VX-950 for the Treatment of Hepatitis
09/29/2011	US20110236350 Estrogen receptor ligand treatment for neurodegenerative diseases
09/29/2011	US20110236349 Use of Epidermal Growth Factor Inhibitors in the Treatment of Viral Infection
09/29/2011	US20110236348 Modulators of toll-like receptor 7
09/29/2011	US20110236347 Monoclonal Anti-Claudin 1 Antibodies for the Inhibition of Hepatitis C Virus Infection
09/29/2011	US20110236346 Compositions and Methods for Treatment of Radiation Exposure
09/29/2011	US20110236345 Composition and methods for eliciting an immune response
09/29/2011	US20110236344 Synthetic mimics of mammalian cell surface receptors: method and compositions
09/29/2011	US20110236325 Methods to treat or prevent a skin condition using a nell1 peptide
09/29/2011	US20110236309 Antagonists of ligands and uses thereof
09/29/2011	US20110236306 Compositions and methods for the removal of biofilms
09/29/2011	US20110236305 Methods for protecting and regenerating bone marrow using cxcr3 agonists and antagonists
09/29/2011	US20110236304 Structural variants of antibodies for improved therapeutic characteristics
09/29/2011	DE102010012556A1 Use of glucose isomerase in treatment or diagnosis of diabetes and metabolic syndrome
09/29/2011	CA2800248A1 Compounds to be used in the treatment of diseases based on the expression of toxic transcripts
09/29/2011	CA2794664A1 Novel peptides and methods for their preparation and use
09/29/2011	CA2794483A1 Vista regulatory t cell mediator protein, vista binding agents and use thereof
09/29/2011	CA2794167A1 Bmp-7 peptides & methods of use
09/29/2011	CA2794165A1 Bmp-4 peptides & methods of use
09/29/2011	CA2793985A1 Proangiogenic compositions, method for preparing same, and uses thereof

1 ... 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 ... 3163